Accelerated Learning on Large Scale Screens using Generative Library Models
Eli N. Weinstein, Andrei Slabodkin, Mattia G. Gollub, Elizabeth B. Wood
TL;DR
Biological machine learning is often data-limited, which LeaVS addresses by co-designing data generation and learning for large-scale sequence screens. By prioritizing measurements of active sequences ($q=1$) and incorporating a marginal likelihood term that leverages a generative library model $p(x)$, LeaVS achieves consistent estimation of $p(y\mid x)$ and dramatic information gains. The approach is validated through theoretical analysis (sparse activity and posterior concentration) and empirical demonstrations on synthetic data, TCR screening, and large-scale antibody experiments, where it yields superior accuracy, calibration, and enrichment of functional sequences. This co-design strategy enables orders-of-magnitude improvements in data efficiency, with implications for accelerating antibody discovery and therapeutic sequence design.
Abstract
Biological machine learning is often bottlenecked by a lack of scaled data. One promising route to relieving data bottlenecks is through high throughput screens, which can experimentally test the activity of $10^6-10^{12}$ protein sequences in parallel. In this article, we introduce algorithms to optimize high throughput screens for data creation and model training. We focus on the large scale regime, where dataset sizes are limited by the cost of measurement and sequencing. We show that when active sequences are rare, we maximize information gain if we only collect positive examples of active sequences, i.e. $x$ with $y>0$. We can correct for the missing negative examples using a generative model of the library, producing a consistent and efficient estimate of the true $p(y | x)$. We demonstrate this approach in simulation and on a large scale screen of antibodies. Overall, co-design of experiments and inference lets us accelerate learning dramatically.
